FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination

BACKGROUND: FTY720 (fingolimod) is the first oral drug approved by the Food and Drug Administration for treatment of patients with the relapsing-remitting form of the human demyelinating disease multiple sclerosis. Evidence suggests that the therapeutic benefit of FTY720 occurs by preventing the egr...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanc, Caroline A, Rosen, Hugh, Lane, Thomas E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148542/
https://www.ncbi.nlm.nih.gov/pubmed/25138356
http://dx.doi.org/10.1186/s12974-014-0138-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148542/
https://www.ncbi.nlm.nih.gov/pubmed/25138356
http://dx.doi.org/10.1186/s12974-014-0138-y

Ejemplares similares